Experimental study on role of cannabinoid receptor 1 in non-alcoholic fatty liver disease among rats

Experimental study on role of cannabinoid receptor 1 in non-alcoholic fatty liver disease among rats

ObjectiveTo observe the expression of endogenous cannabinoid receptor l (CB1) in rats with non-alcoholic fatty liver disease (NAFLD) and to preliminarily investigate the role of CB1 receptors in the pathogenesis of NAFLD. MethodsForty-eight male SD rats were randomly divided into three groups: contr...

Full description

Bibliographic Details
Main Author:	PAN Jing
Format:	Article
Language:	zho
Published:	Editorial Department of Journal of Clinical Hepatology 2013-08-01
Series:	Linchuang Gandanbing Zazhi
Subjects:	fatty liver receptor cannabinoid CB1；leptin tumor necrosis factor-alpha
Online Access:	http://www.lcgdbzz.org/qk_content.asp?id=5434&ClassID=712132651

Similar Items

Subchronic Central Administration of Cannabinoid Ligands Modulates Nociception in Bulbectomized Rats
by: Roman E. Tashev, et al.
Published: (2019-12-01)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019-04-01)

Cannabinoid receptor-1 antagonism: a new perspective on treating a murine schistosomal liver fibrosis model
by: Yasmine Amr Issa, et al.

Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01)

Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1
by: Rachel Dopart, et al.
Published: (2020-01-01)

Synthetic cannabinoids versus delta-9-tetrahydrocannabinol: abuse-related consequences of enhanced efficacy at the cannabinoid 1 receptor
by: Grim, Travis
Published: (2015)

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
by: Dongchen An, et al.
Published: (2020-07-01)

Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats
by: Juan M. Decara, et al.
Published: (2015-10-01)

Effects of cannabinoid modulation on hypothalamic nesfatin-1 and insulin resistance
by: Oktay Kaya, et al.
Published: (2019-01-01)

Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
by: M. Galán-Ganga, et al.
Published: (2021-05-01)

Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling
by: Kayte A. Jenkin, et al.
Published: (2013-11-01)

Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture
by: Su Tang-feng, et al.
Published: (2011-12-01)

CB1 cannabinoid receptor expression in the striatum: Association with corticostriatal circuits and developmental regulation
by: Vincent eVan Waes, et al.
Published: (2012-03-01)

Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone
by: Aysha B. Khalid, et al.
Published: (2015-12-01)

Neuronal Calcium and cAMP Cross-Talk Mediated by Cannabinoid CB1 Receptor and EF-Hand Calcium Sensor Interactions
by: Edgar Angelats, et al.
Published: (2018-07-01)

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis
by: Ana Cabranes, et al.
Published: (2005-11-01)

Orexin-A/Hypocretin-1 Controls the VTA-NAc Mesolimbic Pathway via Endocannabinoid-Mediated Disinhibition of Dopaminergic Neurons in Obese Mice
by: Lea Tunisi, et al.
Published: (2021-02-01)

Type 2 Diabetes Alters Vascular Cannabinoid Receptor 1 Expression, Phosphorylation Status, and Vasorelaxation in Rat Aorta
by: Enrique Sánchez-Pastor, et al.
Published: (2020-10-01)

Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors
by: Srinagesh Mannekote Thippaiah, et al.
Published: (2021-04-01)

Molecular Pharmacology of Synthetic Cannabinoids: Delineating CB1 Receptor-Mediated Cell Signaling
by: Kenneth B. Walsh, et al.
Published: (2020-08-01)

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
by: Giulia Abate, et al.
Published: (2021-06-01)

Los cannabinoides como agentes citoprotectores en la enfermedad de Alzheimer y sus mecanismos de acción
by: Carlos Vélez Pardo, et al.
Published: (2005-03-01)

A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid
by: Hebaallah Mamdouh Hashiesh, et al.
Published: (2021-08-01)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
by: Qing-Rong Liu, et al.
Published: (2020-12-01)

Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
by: Jakub Jakowiecki, et al.
Published: (2021-04-01)

Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Caitlin R. M. Oyagawa, et al.
Published: (2018-11-01)

Rôle du récepteur aux cannabinoïdes CB2 sur la synaptogenèse
by: Fleury, Pascal
Published: (2013)

Rôle du récepteur aux cannabinoïdes CB2 sur la synaptogenèse
by: Fleury, Pascal
Published: (2013)

Protective role of neuronal and lymphoid cannabinoid CB2 receptors in neuropathic pain
by: David Cabañero, et al.
Published: (2020-07-01)

The cannabinoid receptor CB1 affects the proliferation and apoptosis of adenomyotic human uterine smooth muscle cells of the junctional zone: a mechanism study
by: Sha Wang, et al.
Published: (2021-02-01)

Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis
by: Simone Tambaro, et al.
Published: (2010-08-01)

Chain Substituted Cannabilactones with Selectivity for the CB2 Cannabinoid Receptor
by: Shakiru O. Alapafuja, et al.
Published: (2019-10-01)

Erratum: Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Frontiers Production Office
Published: (2019-04-01)

The Cannabinoid CB1 Antagonist TM38837 With Limited Penetrance to the Brain Shows Reduced Fear-Promoting Effects in Mice
by: Vincenzo Micale, et al.
Published: (2019-03-01)

GENE POLYMORPHISM OF PROINFLAMMATORY CYTOKINES (TNF, IL6) AND THEIR RECEPTORS (TNFRSF1A, TNFRSF1B, IL6R): IMPLICATIONS FOR NON-ALCOHOLIC FATTY LIVER DISEASE
by: Lyudmila Topchieva, et al.
Published: (2017-05-01)

CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin
by: Pierre Cardinal, et al.
Published: (2014-10-01)

Role of Cannabinoids in Obesity
by: Francesca Rossi, et al.
Published: (2018-09-01)

Cannabinoids for treatment of Alzheimer’s disease: moving towards the clinic
by: Isidro eFerrer
Published: (2014-03-01)

The role of endocannabinoids system in fatty liver disease and therapeutic potentials
by: Khalid A Alswat
Published: (2013-01-01)

Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19
by: Niraj Kumar Jha, et al.
Published: (2021-08-01)